VIVO OPPORTUNITY, LLC purchased 37.7% of their position (20.55K shares) of INMED PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $31.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 6 purchases
Filed: 7/17/2026ACC: 0001213900-26-078891
10% Owner
Since May 2026
+20.55K
Net shares
Net buyer
$31.8K
Total acquired
6
Open market trades
6B · 0S
6
Total transactions
20.55K acquired
Non-Derivative Transactions6
Common Shares
Indirect
Shares
+4.88K
Price / share
$1.55
Trade value
$7.57K
% of position
0.7%
7/14/2026
724.39K→729.28K
Common Shares
Indirect
Shares
+493.00
Price / share
$1.55
Trade value
$764.15
% of position
0.7%
7/14/2026
73.14K→73.63K
Common Shares
Indirect
Shares
+13.76K
Price / share
$1.55
Trade value
$21.33K
% of position
1.9%
7/15/2026
729.28K→743.04K
Common Shares
Indirect
Shares
+1.39K
Price / share
$1.55
Trade value
$2.15K
% of position
1.9%
7/15/2026
73.63K→75.02K
Common Shares
Indirect
Shares
+19.00
Price / share
$1.55
Trade value
$29.45
% of position
0.0%
7/16/2026
743.04K→743.06K
Common Shares
Indirect
Shares
+2.00
Price / share
$1.55
Trade value
$3.10
% of position
0.0%
7/16/2026
75.02K→75.02K
Total
Net shares
+20.55K
Net value
$31.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 7/14/2026 | P · Purchase | +4.88K | $1.55 | $7.57K | 0.7% | 724.39K | 729.28K |
| Common Shares Indirect | 7/14/2026 | P · Purchase | +493.00 | $1.55 | $764.15 | 0.7% | 73.14K | 73.63K |
| Common Shares Indirect | 7/15/2026 | P · Purchase | +13.76K | $1.55 | $21.33K | 1.9% | 729.28K | 743.04K |
| Common Shares Indirect | 7/15/2026 | P · Purchase | +1.39K | $1.55 | $2.15K | 1.9% | 73.63K | 75.02K |
| Common Shares Indirect | 7/16/2026 | P · Purchase | +19.00 | $1.55 | $29.45 | 0.0% | 743.04K | 743.06K |
| Common Shares Indirect | 7/16/2026 | P · Purchase | +2.00 | $1.55 | $3.10 | 0.0% | 75.02K | 75.02K |
| Total | +20.55K | $31.85K | ||||||
Derivative Transactions0
No derivative transactions reported